Sort
261,768 grants matching “gene therapy”
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy
$841,919Lei Zhu · Migra-Therapeutics, Llc · R44 · FY2023 · CA
Identifying gene-by-environment interplay in health behavior
$841,902Titus Johannes Galama · University Of Southern California · R56 · FY2020 · AG
The Differentiation and Function of heterogeneous populations of Allergen-specific Lung-resident Th2 CD4+ memory cells
$841,731Marion Pepper · University Of Washington · R01 · FY2025 · AI
Antagonize Host Survival and Immune Escape Mechanisms for Elimination of HIV Viral Reservoirs
$841,702Jian Zhu · Ohio State University · R56 · FY2024 · AI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$841,614Abigail Pulsipher · Glycomira, Llc · R44 · FY2019 · AI
Evaluation of Pluripotent Stem Cell-Derived Blood Cells in Nonhuman Primate Model
$841,579Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL
Core--Radiochemistry Laboratory
$841,566Joseph G Rajendran · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Characterization Of Proteins and Other Molecules By Mass Spectrometry
$841,526Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2013 · HD
Microbial biomarkers of intestinal MDR colonization after solid organ transplantation
$841,520Anne-Catrin Uhlemann · Columbia University Health Sciences · R01 · FY2025 · AI
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$841,459Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2018 · CA
Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease
$841,448Kim Tieu · Florida International University · R35 · FY2025 · ES
Targeting the HIV/SIV reservoir at time of ART initiation
$841,447Afamefuna Okoye · Oregon Health & Science University · R01 · FY2023 · AI
Host Genetic Determinants of HIV Pathogenesis
$841,436Sunil K Ahuja · University Of Texas Hlth Science Center · R37 · FY2009 · AI
Small Molecule Therapeutics for Renal Disease
$841,379Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · DK
Identification and functional characterization of colorectal cancer genes
$841,376Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
$841,361Christina Grek · Xequel Bio, Inc. · R44 · FY2018 · CA
Natural History of Familial Carcinoid Tumor
$841,282Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$841,281Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2011 · CA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
$841,251Jane C. Figueiredo · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function
$841,220David Kc Cooper · Massachusetts General Hospital · U19 · FY2022 · AI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$841,182Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2022 · NS
Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic Autism
$841,138Alexander Kolevzon · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Personalized precision dosing of anti-TNF biologic therapies
$841,118Bradley T Messmer · Abreos Biosciences, Inc. · R44 · FY2020 · AI